P38 MAP Kinase inhibition promotes primary tumour growth via VEGF independent mechanism

被引：0
|
作者：
Adrian W O'Sullivan
Jiang H Wang
Henry P Redmond
机构：
[1] National University of Ireland (NUI) and Cork University College Hospital,Department of Academic Surgery
来源：
World Journal of Surgical Oncology | / 7卷
关键词：
Mitogen Activate Protein Kinase; Primary Tumour Growth; Mitogen Activate Protein Kinase Family; VEGF Release; Biological Service Unit;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Inhibitors of unactivated p38 MAP kinase
    Bullington, James
    Argentieri, Dennis
    Averill, Kristin
    Carter, Demetrius
    Cavender, Druie
    Fahmy, Bohumila
    Fan, Xiaodong
    Hall, Daniel
    Heintzelman, Geoffrey
    Jackson, Paul
    Leung, Wai-Ping
    Li, Xun
    Ling, Ping
    Olini, Gilbert
    Razler, Thomas
    Reuman, Michael
    Rupert, Kenneth
    Russell, Ronald
    Siekierka, John
    Wadsworth, Scott
    Wolff, Russell
    Xiang, Bangping
    Zhang, Yue-Mei
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (23) : 6102 - 6106
  • [22] Therapeutic Potential of p38 MAP Kinase Inhibition in the Management of Cardiovascular Disease
    Marie Fisk
    Parag R. Gajendragadkar
    Kaisa M. Mäki-Petäjä
    Ian B. Wilkinson
    Joseph Cheriyan
    American Journal of Cardiovascular Drugs, 2014, 14 : 155 - 165
  • [23] INHIBITION OF p38 MAP KINASE BY UTILIZING A NOVEL ALLOSTERIC BINDING SITE
    Tong, L.
    Pargellis, C.
    Churchill, L.
    Cirillo, P.
    Gilmore, T.
    Graham, A. G.
    Grob, P. M.
    Hickey, E. R.
    Moss, N.
    Pav, S.
    Regan, J.
    ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 2002, 58 : C231 - C231
  • [24] Continued exploration of the triazolopyridine scaffold as a platform for p38 MAP kinase inhibition
    Jerome, Kevin D.
    Rucker, Paul V.
    Xing, Li
    Shieh, Huey S.
    Baldus, John E.
    Selness, Shaun R.
    Letavic, Michael A.
    Braganza, John F.
    McClure, Kim F.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (02) : 469 - 473
  • [25] Effect of selective inhibition of the p38 MAP kinase pathway on platelet aggregation
    Kuliopulos, A
    Mohanlal, R
    Covic, L
    THROMBOSIS AND HAEMOSTASIS, 2004, 92 (06) : 1387 - 1393
  • [26] Therapeutic Potential of p38 MAP Kinase Inhibition in the Management of Cardiovascular Disease
    Fisk, Marie
    Gajendragadkar, Parag R.
    Maeki-Petaejae, Kaisa M.
    Wilkinson, Ian B.
    Cheriyan, Joseph
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2014, 14 (03) : 155 - 165
  • [27] Inhibition of p38 MAP kinase by utilizing a novel allosteric binding site
    Pargellis, C
    Tong, L
    Churchill, L
    Cirillo, PF
    Gilmore, T
    Graham, AG
    Grob, PM
    Hickey, ER
    Moss, N
    Pav, S
    Regan, J
    NATURE STRUCTURAL BIOLOGY, 2002, 9 (04) : 268 - 272
  • [28] P38 MAP kinase inhibition enables proliferation of adult mammalian cardiomyocytes
    Engel, FB
    Schebesta, M
    Duong, MT
    Lu, G
    Ren, SX
    Madwed, JB
    Jiang, HP
    Wang, Y
    Keating, MT
    GENES & DEVELOPMENT, 2005, 19 (10) : 1175 - 1187
  • [29] Inhibition of Inflammation by a p38 MAP Kinase Targeted Cell Permeable Peptide
    Fu, Jing
    Meng, Xianmei
    He, Junyun
    Gu, Jun
    MEDICINAL CHEMISTRY, 2008, 4 (06) : 597 - 604
  • [30] Inhibition of p38 MAP kinase by utilizing a novel allosteric binding site
    Christopher Pargellis
    Liang Tong
    Laurie Churchill
    Pier F. Cirillo
    Thomas Gilmore
    Anne G. Graham
    Peter M. Grob
    Eugene R. Hickey
    Neil Moss
    Susan Pav
    John Regan
    Nature Structural Biology, 2002, 9 : 268 - 272
12345